Latest Conference Articles

April 28th 2016, 8:03am

Oncology Nursing Society Congress

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the concept she developed to manage dermatologic adverse events for patients with cancer.

April 28th 2016, 8:01am

Oncology Nursing Society Congress

When chemotherapy involves tricky infusion timing, patients are routinely admitted to hospitals to receive their treatments. But what would happen if these drugs could be administered successfully on an outpatient basis?

April 28th 2016, 8:01am

Oncology Nursing Society Congress

West Cancer Center researchers developed a best nursing practice protocol for titration of fentanyl sublingual spray, which is the most recently approved transmucosal immediate-release fentanyl formulation.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Researchers at the Rutgers Cancer Institute of New Jersey are testing the possibility of sending treatment drugs directly to the kidney in patients with upper urinary tract urothelial carcinoma.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

When oncology nurses move proactively to learn more about and use proven effective green-lighted interventions like exercise and muscle relaxation in their daily practice, it can go a long way.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

A multidisciplinary team led by oncology nurses can reduce both hospitalization and treatment breaks for patients with head and neck cancer.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Ellyn Matthews, PhD, RN, AOCNS, CBSM, who holds the Elizabeth Stanley Cooper Endowed Chair in Oncology Nursing at the University of Arkansas for Medical Sciences, addresses common misconceptions that patients with cancer have about sleep disturbances.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Jeannine Brant, PhD, Billings Clinic, discusses the benefits of patient-reported outcomes in cancer care.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Cancer doesn’t discriminate, but that doesn’t mean the healthcare system won’t. This proves to be even more true for the lesbian, gay, bisexual and transgender community.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Lots of people take their work home with them, but Lynne Malestic, RN, has given the idea new meaning.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Carmela Hoefling, RN, MSN, APN-C, AOCNP, advanced practice nurse, Gastrointestinal/Hepatobiliary Oncology Program, Rutgers Cancer Institute of New Jersey, discusses the effects that malnourishment can have on surgery.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Joel Stettler, BSN, RN, OCN, Moffitt Cancer Center, discusses procedures implemented at his institution for patients who are at risk for falls. 

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Developing a skin rash as a result of EGFR-inhibitor targeted therapy often signals that the drug is working, but for patients who experience these serious dermatologic adverse events, it may become so intolerable that they will scale back or even discontinue anticancer medications that could prolong their survival.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

With the growing use of oral therapies in cancer care, it is crucial that oncology nurses are using a systematic approach to assess and improve adherence, according to Whitney Perry, APRN, AOCNP.

April 28th 2016, 7:50am

Oncology Nursing Society Congress

The possibility that hospitalized cancer patients will fall is an ongoing concern among the medical professionals who care for them.

April 28th 2016, 7:42am

Oncology Nursing Society Congress

Darcy Burbage, RN, MSN, AOCN, CBCN, Helen F. Graham Cancer Center & Research Institute, discusses the role nurses play in treating patients with chemotherapy-induced peripheral neuropathy (CIPN).

April 26th 2016, 12:25pm

Community Oncology Conference

David Eagle, MD, past president of the Community Oncology Alliance (COA) and partner in Lake Norman Oncology, Mooresville, North Carolina, discuss controlling costs of cancer treatment.

April 26th 2016, 9:43am

School of Gastrointestinal Oncology

Jeff Geschwind, MD, professor and chairman, Radiology and Biomedical Imaging, Yale Cancer Center, discusses locoregional treatment options for patients with hepatocellular carcinoma (HCC).

April 26th 2016, 9:13am

School of Gastrointestinal Oncology

A number of novel therapies are currently being explored as second-line treatments for patients with advanced hepatocellular carcinoma, including a host of targeted therapies and various immune checkpoint inhibitors.

April 26th 2016, 9:04am

School of Gastrointestinal Oncology

Immunotherapy approaches are showing early signs of activity against a range of gastrointestinal cancers, defying the skeptical view that these tumors would not respond to the emerging agents succeeding in other malignancies.